Patents by Inventor Jennifer Jenkins

Jennifer Jenkins has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230167348
    Abstract: A heat transfer fluid for electrical applications includes water soluble glycol 5 wt. % to 98 wt. %, demineralized water 0 wt. % to 95 wt. %, and a total dissolved solid inorganic additive content in the heat transfer fluid of 0.1 wt. % to 2 wt. %. The electrical conductivity of the heat transfer fluid is 100 ?S/cm to 5000 ?S/cm.
    Type: Application
    Filed: December 1, 2021
    Publication date: June 1, 2023
    Inventors: Ying Yang, Samuel Elliott, Jennifer Jenkins, David E. Turcotte, Dale Reid, Virginia Whittington-Byrd, Michael King
  • Publication number: 20230130851
    Abstract: Described herein are modified fibroblast growth factor (FGF) polypeptides, pharmaceutical compositions and medicaments that include such modified FGF polypeptides, and methods of using such modified FGF polypeptides to treat or prevent conditions that benefit from administration of FGFs.
    Type: Application
    Filed: September 7, 2022
    Publication date: April 27, 2023
    Inventors: David EVELETH, Jennifer JENKINS-EVELETH, Amuthakannan SUBRAMANIAM, Ralph BRADSHAW
  • Patent number: 11479591
    Abstract: Described herein are modified fibroblast growth factor (FGF) polypeptides, pharmaceutical compositions and medicaments that include such modified FGF polypeptides, and methods of using such modified FGF polypeptides to treat or prevent conditions that benefit from administration of FGFs.
    Type: Grant
    Filed: May 4, 2018
    Date of Patent: October 25, 2022
    Assignee: TREFOIL THERAPEUTICS, INC.
    Inventors: David Eveleth, Jennifer Jenkins-Eveleth, Amuthakannan Subramaniam, Ralph Bradshaw
  • Publication number: 20200190158
    Abstract: Described herein are modified fibroblast growth factor (FGF) polypeptides, pharmaceutical compositions and medicaments that include such modified FGF polypeptides, and methods of using such modified FGF polypeptides to treat or prevent conditions that benefit from administration of FGFs.
    Type: Application
    Filed: May 4, 2018
    Publication date: June 18, 2020
    Inventors: David EVELETH, Jennifer JENKINS-EVELETH, Amuthakannan SUBRAMANIAM, Ralph BRADSHAW
  • Patent number: 7115399
    Abstract: Method for measuring potency of a substance, the method including; administering the substance to a mammal; subjecting the mammal to a stimulus; and monitoring a pinna reflex response of the mammal.
    Type: Grant
    Filed: July 16, 2002
    Date of Patent: October 3, 2006
    Assignee: Allergan, Inc.
    Inventor: Jennifer A. Jenkins
  • Publication number: 20030032891
    Abstract: Method for measuring potency of a substance, the method including; administering the substance to a mammal; subjecting the mammal to a stimulus; and monitoring a pinna reflex response of the mammal.
    Type: Application
    Filed: July 16, 2002
    Publication date: February 13, 2003
    Applicant: Allergan, Inc.
    Inventor: Jennifer A. Jenkins